Ascendis Pharma
ASND
$143.18
Share price
-1.14%
Change (1 day)
79.49%
Change (1 year)
Categories
EPS for Ascendis Pharma (ASND)
EPS in 2023 (TTM): -$11.45
According to Ascendis Pharma 's latest financial reports the company's current EPS (TTM) is -$11.45. In 2022 the company made an earnings per share (EPS) of -$10.93 a decrease over its 2021 EPS that were of -$8.17.
EPS history for Ascendis Pharma from 2014 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$11.45 | 4.71% |
| 2022 | -$10.93 | 33.81% |
| 2021 | -$8.17 | -15.17% |
| 2020 | -$9.63 | 81.84% |
| 2019 | -$5.30 | 40.52% |
| 2018 | -$3.77 | -11.13% |
| 2017 | -$4.24 | 48.1% |
| 2016 | -$2.86 | 90.33% |
| 2015 | -$1.50 | 78.25% |
| 2014 | -$0.84 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Akebia Therapeutics AKBA | -$0.64 | -94.41% | 🇺🇸 USA |
 Affimed
AFMD | -$0.79 | -93.10% | 🇩🇪 Germany |
 Advaxis ADXS | -$5.97 | -47.85% | 🇺🇸 USA |